{"id":"https://openalex.org/W7224923393","doi":"https://doi.org/10.1186/s13063-026-10054-5","title":"Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial","display_name":"Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224923393","doi":"https://doi.org/10.1186/s13063-026-10054-5"},"language":"en","primary_location":{"id":"doi:10.1186/s13063-026-10054-5","doi":"https://doi.org/10.1186/s13063-026-10054-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-026-10054-5","pdf_url":null,"source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s13063-026-10054-5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027788266","display_name":"Aaron P. Kithcart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron P. Kithcart","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120310588","display_name":"Margaret Onisko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Onisko","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125549560","display_name":"Wanxue Zou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wanxue Zou","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160229524","display_name":"Siyu Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siyu Li","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047444663","display_name":"Jos\u00e9 G. Raya","orcid":"https://orcid.org/0000-0002-7202-5712","observed_orcids":["https://orcid.org/0000-0002-7202-5712"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 G. Raya","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014707733","display_name":"David E. Gutstein","orcid":"https://orcid.org/0000-0001-7776-3477","observed_orcids":["https://orcid.org/0000-0001-7776-3477"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Gutstein","raw_affiliation_strings":["Regeneron Pharmaceuticals, Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114772035","display_name":"Chase W. Smitterberg","orcid":"https://orcid.org/0000-0001-8509-8120","observed_orcids":["https://orcid.org/0000-0001-8509-8120"]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chase W. Smitterberg","raw_affiliation_strings":["Department of Orthopaedic Surgery, Sinai Hospital of Baltimore, The Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Orthopaedic Surgery, Sinai Hospital of Baltimore, The Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108083499","display_name":"Michael A. Mont","orcid":"https://orcid.org/0000-0003-4303-5556","observed_orcids":["https://orcid.org/0000-0003-4303-5556"]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael A. Mont","raw_affiliation_strings":["Department of Orthopaedic Surgery, Sinai Hospital of Baltimore, The Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Orthopaedic Surgery, Sinai Hospital of Baltimore, The Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108083499"],"corresponding_institution_ids":["https://openalex.org/I2800667924"],"apc_list":{"value":2790,"currency":"USD","value_usd":2790},"apc_paid":{"value":2790,"currency":"USD","value_usd":2790},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.88780155,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10562","display_name":"Total Knee Arthroplasty Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xi-inhibition","display_name":"factor XI inhibition","score":0.8159999847412109},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.8140000104904175},{"id":"https://openalex.org/keywords/venous-thrombosis-prophylaxis","display_name":"venous thrombosis prevention","score":0.8840000033378601},{"id":"https://openalex.org/keywords/total-knee-arthroplasty","display_name":"total knee arthroplasty","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.718999981880188},{"id":"https://openalex.org/keywords/postoperative-thrombosis","display_name":"postoperative thrombosis","score":0.6679999828338623},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.675000011920929},{"id":"https://openalex.org/keywords/orthopedic-surgery-complications","display_name":"orthopedic surgery complications","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9786999821662903},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6255999803543091},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5878999829292297},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5875999927520752},{"id":"https://openalex.org/C2778589496","wikidata":"https://www.wikidata.org/wiki/Q487937","display_name":"Hemostasis","level":2,"score":0.529699981212616},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5285999774932861},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.517799973487854},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.49619999527931213},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.460099995136261},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.43220001459121704},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.41670000553131104},{"id":"https://openalex.org/C2778336525","wikidata":"https://www.wikidata.org/wiki/Q708178","display_name":"Arthroplasty","level":2,"score":0.40869998931884766},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.38429999351501465},{"id":"https://openalex.org/C2778959117","wikidata":"https://www.wikidata.org/wiki/Q430892","display_name":"Deep vein","level":3,"score":0.37310001254081726},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.36550000309944153},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3562999963760376},{"id":"https://openalex.org/C2779851652","wikidata":"https://www.wikidata.org/wiki/Q4107209","display_name":"Venous stasis","level":2,"score":0.35179999470710754},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.3458000123500824},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3206000030040741},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.31850001215934753},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.3172999918460846},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.3138999938964844},{"id":"https://openalex.org/C2775965419","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter trial","level":4,"score":0.29809999465942383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2955999970436096},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.2922999858856201},{"id":"https://openalex.org/C2778825682","wikidata":"https://www.wikidata.org/wiki/Q416516","display_name":"Enoxaparin sodium","level":4,"score":0.28850001096725464},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.28769999742507935},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.27730000019073486},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.26429998874664307},{"id":"https://openalex.org/C73751289","wikidata":"https://www.wikidata.org/wiki/Q2985397","display_name":"Data monitoring committee","level":3,"score":0.26429998874664307}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1186/s13063-026-10054-5","doi":"https://doi.org/10.1186/s13063-026-10054-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-026-10054-5","pdf_url":null,"source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1186/s13063-026-10054-5","doi":"https://doi.org/10.1186/s13063-026-10054-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-026-10054-5","pdf_url":null,"source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7164051273","https://openalex.org/W2774512065","https://openalex.org/W2897018445","https://openalex.org/W2792430856","https://openalex.org/W2947458293","https://openalex.org/W3161721103","https://openalex.org/W4255247183","https://openalex.org/W3000508019","https://openalex.org/W4292840770","https://openalex.org/W2040206034"],"abstract_inverted_index":{"Venous":[0],"thromboembolism":[1],"(VTE)":[2],"remains":[3],"a":[4,84,126,160,227,305],"common":[5,264],"and":[6,69,104,203,232,243],"serious":[7],"complication":[8],"following":[9,122,275],"total":[10],"knee":[11],"arthroplasty":[12],"(TKA).":[13],"Despite":[14],"guideline":[15],"variability,":[16],"acetylsalicylic":[17],"acid":[18],"(aspirin;":[19],"ASA)":[20],"is":[21,83,125,226,270],"widely":[22],"used":[23],"for":[24,139,212,272],"postoperative":[25,115,219,273],"thromboprophylaxis,":[26],"particularly":[27],"in":[28,51,97,142,159,267,308,321],"the":[29,91,154,263,316],"United":[30],"States.":[31],"While":[32],"anticoagulants":[33],"are":[34],"associated":[35,282],"with":[36,137,174,215,283,290],"lower":[37],"VTE":[38,116,140,231,299],"rates":[39],"than":[40,120],"ASA,":[41,291],"concerns":[42,281],"regarding":[43],"bleeding":[44,280,309],"risk":[45],"continue":[46,211],"to":[47,90,134,163,206,295],"limit":[48],"their":[49],"use":[50],"routine":[52],"practice.":[53,324],"Therapeutic":[54],"strategies":[55],"that":[56,88,112],"target":[57,149],"thrombosis":[58],"while":[59],"preserving":[60],"hemostasis":[61],"may":[62,313],"offer":[63],"an":[64,257],"improved":[65],"balance":[66],"of":[67,72,94,99,150,171,185,229,279,318,332],"risks":[68],"benefits;":[70],"inhibition":[71,289,320],"factor":[73],"XI":[74],"(FXI)":[75],"represents":[76],"one":[77],"such":[78],"approach.":[79],"Cenvacibart":[80],"(previously":[81],"REGN7508)":[82],"human":[85],"monoclonal":[86],"antibody":[87],"binds":[89],"catalytic":[92],"domain":[93],"FXI,":[95],"resulting":[96],"suppression":[98],"activated":[100],"FXI":[101,288,319],"(FXIa)":[102],"activity":[103],"downstream":[105],"coagulation.":[106],"Phase":[107],"2":[108],"clinical":[109,216,265],"data":[110],"demonstrated":[111],"cenvacibart":[113,136,166],"reduced":[114],"events":[117,251],"more":[118],"effectively":[119],"enoxaparin":[121],"TKA.":[123,147],"ROXI-ASPEN":[124,261],"phase":[127],"3,":[128,335],"randomized,":[129],"double-blind,":[130],"multicenter":[131],"trial":[132],"designed":[133],"compare":[135],"ASA":[138,191,269],"prophylaxis":[141],"adults":[143,152],"undergoing":[144],"elective,":[145],"primary":[146,223,276],"A":[148],"2000":[151],"from":[153],"USA":[155],"will":[156,197,210,252],"be":[157,198,253,302],"randomized":[158],"1:1":[161],"ratio":[162],"receive":[164],"either":[165],"administered":[167,181],"within":[168,182],"three":[169,183],"hours":[170,184],"wound":[172,186],"closure":[173,187],"oral":[175,190],"placebo":[176,180],"twice":[177,194],"daily,":[178],"or":[179],"followed":[188],"by":[189,200,256],"81":[192],"mg":[193],"daily.":[195],"Randomization":[196],"stratified":[199],"geographic":[201],"region":[202],"performed":[204],"prior":[205],"surgery.":[207],"Study":[208],"treatment":[209],"30":[213],"days,":[214],"follow-up":[217],"through":[218,235],"day":[220,236],"90.":[221],"The":[222,311],"efficacy":[224],"endpoint":[225],"composite":[228],"symptomatic":[230],"VTE-related":[233],"death":[234],"30.":[237],"Key":[238],"secondary":[239],"endpoints":[240],"include":[241],"major":[242],"clinically":[244],"relevant":[245],"non-major":[246],"bleeding.":[247],"All":[248],"suspected":[249],"outcome":[250],"centrally":[254],"adjudicated":[255],"independent,":[258],"blinded":[259],"committee.":[260],"addresses":[262],"scenario":[266],"which":[268],"selected":[271],"thromboprophylaxis":[274],"TKA":[277],"because":[278],"anticoagulants.":[284],"By":[285],"directly":[286],"comparing":[287],"this":[292],"study":[293],"seeks":[294],"clarify":[296],"whether":[297],"enhanced":[298],"protection":[300],"can":[301],"achieved":[303],"without":[304],"corresponding":[306],"increase":[307],"risk.":[310],"findings":[312],"help":[314],"define":[315],"role":[317],"contemporary":[322],"orthopedic":[323],"ClinicalTrials.gov":[325],"identifier:":[326],"NCT07213778":[327],"(":[328],"https://clinicaltrials.gov/study/NCT07213778":[329],");":[330],"Date":[331],"registration:":[333],"October":[334],"2025.":[336]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}